Abbott cuts prices to VHA under renegotiated sole-source contract, adds Carpuject syringe to agreement.
This article was originally published in The Gray Sheet
Executive Summary
ABBOTT/VHA SUPPLY DEAL RENEGOTIATED IN RESPONSE TO PRICING PRESSURE for intravenous supplies and other products covered under the contract. Abbott's existing sole-source deal with VHA was set to expire in 1999, but VHA renegotiated the agreement in light of lower prices in markets covered by the deal. The supply pact includes I.V. supplies, parenteral nutritionals and compounding systems, electronic drug delivery systems, critical care products, and injectable drugs and delivery systems.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.